of the Core Since the establishment of the Molecular Biology/Gene Expression Core in 1997, this facility has been an invaluable resource to the members of the Center through the following measures: 1) Acquiring and distributing important digestive disease related reagents. 2) Acquiring and supporting the maintenance of a dozen analytic instruments as well as software critical for the quantification and analysis of gene expression. 3) Subsidizing the cost of important technical services important in the molecular analysis of data generated from Center related investigation. Services include access to the Penn Microarray Facility, bioinformatics datamining support through the Penn Genomic Frontiers Institute, and newly established access to the Molecular Biomarker Services through the Penn Center of Excellence in Environmental Toxicology. 4) Maintenance of a human sample biorepository with annotated clinical metadata. The success of this Core can be measured by examining several parameters: A) Core usage, B) Evidence of collaborative work amongst Center Investigators as well as the expansion of the Junior Investigator (associate members) base, and C) Publications relating to the use of this Core. The Core has undergone significant maturation in format and services in order to augment the scientific accomplishments of investigators utilizing the Molecular Biology Core/Gene Expression Core. Due to the growing level of interest in the acquisition of human tissues and biosamples by the Center membership. Dr. Wu has made an investment into the development of a Human Sample Biorepository and an associated Database Repository, which has been embraced by Penn's School of Medicine and endorsed by the External Advisory Board. While these two components of the Core have had a significant level of utilization over the past 5 years, moving forward for the next funding cycle, the Core will enhance the collection of clinical metadata along with the archiving of human biospecimens by partnering with biobanking initiatives recently launched by the Penn School of Medicine. These new initiatives will include the use of tissue inventory software caTissue Suite v1.1 to archive tissue specimens and the use of the Abramson Cancer Center Applied Research Database (ACCARD) to query clinical metadata collected in the EPIC electronic medical record and stored in the Penn Data Store.
| Benias, Petros C; Wells, Rebecca G; Sackey-Aboagye, Bridget et al. (2018) Structure and Distribution of an Unrecognized Interstitium in Human Tissues. Sci Rep 8:4947 |
| Mizuno, Rei; Chatterji, Priya; Andres, Sarah et al. (2018) Differential Regulation of LET-7 by LIN28B Isoform-Specific Functions. Mol Cancer Res 16:403-416 |
| Aiello, Nicole M; Maddipati, Ravikanth; Norgard, Robert J et al. (2018) EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration. Dev Cell 45:681-695.e4 |
| Whelan, Kelly A; Muir, Amanda B; Nakagawa, Hiroshi (2018) Esophageal 3D Culture Systems as Modeling Tools in Esophageal Epithelial Pathobiology and Personalized Medicine. Cell Mol Gastroenterol Hepatol 5:461-478 |
| Friedman, Elliot S; Bittinger, Kyle; Esipova, Tatiana V et al. (2018) Microbes vs. chemistry in the origin of the anaerobic gut lumen. Proc Natl Acad Sci U S A 115:4170-4175 |
| Chatterji, Priya; Rustgi, Anil K (2018) RNA Binding Proteins in Intestinal Epithelial Biology and Colorectal Cancer. Trends Mol Med 24:490-506 |
| Wang, Amber W; Wangensteen, Kirk J; Wang, Yue J et al. (2018) TRAP-seq identifies cystine/glutamate antiporter as a driver of recovery from liver injury. J Clin Invest 128:2297-2309 |
| Lang, Fengchao; Sun, Zhiguo; Pei, Yonggang et al. (2018) Shugoshin 1 is dislocated by KSHV-encoded LANA inducing aneuploidy. PLoS Pathog 14:e1007253 |
| Giroux, Véronique; Stephan, Julien; Chatterji, Priya et al. (2018) Mouse Intestinal Krt15+ Crypt Cells Are Radio-Resistant and Tumor Initiating. Stem Cell Reports 10:1947-1958 |
| Barnoud, Thibaut; Budina-Kolomets, Anna; Basu, Subhasree et al. (2018) Tailoring Chemotherapy for the African-Centric S47 Variant of TP53. Cancer Res 78:5694-5705 |
Showing the most recent 10 out of 700 publications
